AtomwisePRIVATE · FOUNDED 2012
NantOmicsPRIVATE · FOUNDED 2013Each bar is the last disclosed mark — $320M for Atomwise (basis undisclosed, Aug 2020) and $100M for NantOmics (basis undisclosed, May 2022).


AtomwisePRIVATEBiotechnology · US · 2012
NantOmicsPRIVATEBiotechnology · US · 2013
The $320M tells you…
The $100M tells you…At least one valuation basis is undisclosed, so the two numbers stay side by side, each with its own chip, and no ratio is scored. Both are private: there is no public quote and no Canborsa market on either name.
Atomwise operates in Biotechnology / AI drug discovery, and NantOmics operates in Biotechnology / molecular diagnostics.
Atomwise is valued at $320M, and NantOmics at $100M.
Atomwise's lead investors include B Capital Group and Sanabil Investments, and NantOmics' include NantWorks.
Atomwise's headquarters is in San Francisco, California; NantOmics' is in Culver City, California.